{
  "meeting": "AASLD The Liver Meeting 2026 (synthetic)",
  "snapshot_date": "2026-04-26",
  "abstracts": [
    {
      "id": "AASLD-SYN-2026-001",
      "title": "Long-term resmetirom exposure and synthetic real-world fibrosis regression (synthetic)",
      "drugs": ["resmetirom"],
      "topic": "efficacy",
      "track": "MASH"
    },
    {
      "id": "AASLD-SYN-2026-002",
      "title": "Efruxifermin synthetic 96-week histology readout (synthetic)",
      "drugs": ["efruxifermin"],
      "topic": "efficacy",
      "track": "MASH"
    },
    {
      "id": "AASLD-SYN-2026-003",
      "title": "Pemvidutide synthetic IMPACT-Synth topline (synthetic)",
      "drugs": ["pemvidutide"],
      "topic": "efficacy",
      "track": "MASH"
    },
    {
      "id": "AASLD-SYN-2026-004",
      "title": "Survodutide MASH synthetic dose-response (synthetic)",
      "drugs": ["survodutide"],
      "topic": "efficacy",
      "track": "MASH"
    },
    {
      "id": "AASLD-SYN-2026-005",
      "title": "Pegozafermin F4 synthetic interim safety (synthetic)",
      "drugs": ["pegozafermin"],
      "topic": "safety",
      "track": "MASH"
    },
    {
      "id": "AASLD-SYN-2026-006",
      "title": "Lanifibranor synthetic NATIV3-Synth DSMB update (synthetic)",
      "drugs": ["lanifibranor"],
      "topic": "safety",
      "track": "MASH"
    },
    {
      "id": "AASLD-SYN-2026-007",
      "title": "Denifanstat synthetic alopecia adjudication (synthetic)",
      "drugs": ["denifanstat"],
      "topic": "safety",
      "track": "MASH"
    }
  ]
}
